DalsnaFinance › IPOs › Nasus Pharma › IPO
Nasus Pharma Ltd completed its initial public offering on NYSE on August 13, 2025, pricing at $8.00 a share.
| Ticker | NSRX |
|---|---|
| Exchange | NYSE |
| Status | Completed |
| Listing date | August 13, 2025 |
| Offering price | $8.00 |
| Shares offered | 1,250,000 |
| Total raised | $10M |
Nasus Pharma Ltd sold 1,250,000 shares at $8.00 each on NYSE. Multiplied out, that is $10 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $10 million total recorded for the deal.
Measured by money raised, Nasus Pharma Ltd was tied for the 449th largest (level with 24 other deals) of 473 completed IPOs with a recorded deal size that this site tracks since October 5, 2024. The median deal in the same window raised $200 million.
Among the 126 listings on NYSE alone, it is tied for the 114th largest (level with 12 other listings).
August 2025 saw 21 completed IPOs in the site's data; by amount raised, Nasus Pharma Ltd was the 21st largest of the 21 deals with a recorded size.
Its $8.00 offer price was tied for the 409th highest (level with 5 other listings) of the 479 listings in the window with a recorded price. A share price on its own says nothing about a company's value; it depends on how many shares exist.
Nasus Pharma Ltd — quote, profile and latest news →
Source: SEC EDGAR filings for Nasus Pharma Ltd. This page is general information, not investment advice.